Medicare does not cover Mounjaro for prediabetes

Medicare Part D (prescription drug coverage) does not pay for Mounjaro when prescribed for prediabetes. The drug is approved by the FDA for type 2 diabetes only. Medicare will cover Mounjaro if you have a type 2 diabetes diagnosis, but not if your diagnosis is prediabetes alone.

This matters because Mounjaro (tirzepatide) is increasingly prescribed off-label for prediabetes — meaning doctors prescribe it for a condition other than its FDA-approved use. Insurance companies, including Medicare, typically do not cover off-label prescriptions unless there is strong clinical evidence and the plan has made an exception. For prediabetes, that exception is rare.

If your doctor has recommended Mounjaro for prediabetes, you have three practical paths: pay out of pocket, explore whether your plan will cover it through an exception request, or discuss alternative medications that Medicare does cover for prediabetes management.

Key Takeaways

  • Medicare Part D covers Mounjaro only for type 2 diabetes, not for prediabetes, because the drug is not FDA-approved for prediabetes treatment.
  • Your doctor can request a coverage exception from Medicare, but approval is uncommon for off-label prediabetes use and takes two to four weeks.
  • If you have both prediabetes and type 2 diabetes, Medicare will cover Mounjaro under the diabetes diagnosis.
  • Out-of-pocket Mounjaro costs roughly $900 to $1,300 per month without insurance, though the manufacturer offers a savings card that may lower your cost.
  • Medicare covers other medications for prediabetes management, including metformin and some GLP-1 drugs prescribed for weight loss in people with obesity.

Why Medicare's coverage rules depend on FDA approval

Medicare Part D follows a formulary — a list of covered drugs — that is built around FDA-approved uses. When the FDA approves a drug, it approves it for a specific condition. Mounjaro was approved for type 2 diabetes in 2022. Prediabetes is a different diagnosis, and the FDA has not approved Mounjaro for it.

Doctors are legally allowed to prescribe any approved drug for any condition (this is called off-label prescribing), and many do. But insurance — including Medicare — is not required to pay for off-label use. Some plans will cover off-label prescriptions if the doctor makes a case that it is medically necessary and supported by evidence. Medicare Part D plans vary in how willing they are to do this.

The distinction matters because prediabetes and type 2 diabetes are different stages of the same disease process. Prediabetes means your blood sugar is higher than normal but not yet in the diabetic range. Some people with prediabetes progress to type 2 diabetes; others do not. Because Mounjaro is not FDA-approved for prediabetes, Medicare does not automatically cover it for that diagnosis.

How to request a coverage exception from your Medicare plan

If your doctor believes Mounjaro is medically necessary for your prediabetes, they can submit a prior authorization request (also called a coverage exception request) to your Medicare Part D plan. This is a formal ask for the plan to cover a drug that is not on its formulary or is restricted.

Your doctor's office usually handles this. They will write a letter explaining why Mounjaro is appropriate for you — for example, if you have failed other treatments, have a high risk of progression to diabetes, or have a medical reason you cannot take standard prediabetes medications. The plan then reviews the request, usually within two to four weeks.

Approval is not may provide. Many Medicare plans deny prior authorization requests for off-label prediabetes use because the evidence base is still developing and because standard treatments (metformin, lifestyle changes) are considered first-line. If your plan denies the request, you can ask your doctor to appeal, but this adds time and often does not change the outcome.

Before your doctor submits the request, ask them directly: "Do you think the plan will cover this?" Experienced offices know which plans are more flexible and can tell you whether it is worth the effort.

What Mounjaro costs without Medicare coverage

Mounjaro's retail price is approximately $900 to $1,300 per month, depending on your pharmacy and location. This is the price before any discounts or information.

The manufacturer, Eli Lilly, offers a savings card that can reduce your out-of-pocket cost to as little as $25 per month if you have commercial insurance or are uninsured. However, this card typically does not work with Medicare. If you are on Medicare and paying out of pocket, you may still be able to use the card — ask your pharmacy to run it — but coverage is not may provide.

Some community health centers and patient information programs offer Mounjaro at reduced cost or free to people who meet income requirements. Your doctor's office can point you toward these programs, or you can contact Eli Lilly's patient information line directly.

Medicare coverage if you have both prediabetes and type 2 diabetes

If you have been diagnosed with type 2 diabetes — even if you also have a prediabetes label in your chart — Medicare Part D will cover Mounjaro under the diabetes diagnosis. The prediabetes label becomes secondary.

This is an important distinction because some people are diagnosed with prediabetes first, then progress to type 2 diabetes months or years later. Once the type 2 diabetes diagnosis is documented, your coverage changes. If you are unsure whether your diagnosis is prediabetes only or type 2 diabetes, ask your doctor to clarify what is in your medical record, because that is what Medicare will see.

Other medications Medicare covers for prediabetes

Medicare Part D does cover several medications that help manage prediabetes or reduce the risk of progression to type 2 diabetes. Metformin is the standard first-line medication and is covered by all Medicare Part D plans. It is inexpensive and has a long track record in prediabetes prevention.

Some GLP-1 drugs (like semaglutide, sold as Ozempic or Wegovy) are covered by Medicare when prescribed for weight loss in people with obesity, even if prediabetes is the primary reason for the prescription. Coverage depends on your specific plan and whether your doctor documents obesity as a diagnosis. This is a gray area, and approval is not automatic, but it is more common than coverage for Mounjaro in prediabetes.

Your doctor can also refer you to a diabetes prevention program, which Medicare covers at no cost. These programs combine education, nutrition counseling, and exercise support and have strong evidence for preventing or delaying type 2 diabetes in people with prediabetes.

What to do if your doctor prescribes Mounjaro for prediabetes

Start by asking your doctor three questions: (1) Is there a reason I cannot take metformin or another first-line medication? (2) Do you think Medicare will cover Mounjaro for prediabetes, or should I expect to pay out of pocket? (3) If I pay out of pocket, can I use the manufacturer's savings card?

If your doctor still recommends Mounjaro and you want to pursue it, ask them to submit a prior authorization request to your Medicare plan. This costs nothing and takes a few weeks. While you wait, ask your pharmacy to run the Eli Lilly savings card to see if you are may be able to access for the $25 copay option.

If the prior authorization is denied and you cannot afford the full price, talk to your doctor about alternatives: metformin, a diabetes prevention program, or waiting to see if your diagnosis changes to type 2 diabetes (at which point Medicare will cover Mounjaro automatically).

Frequently Asked Questions

Will Medicare cover Mounjaro if I have prediabetes and obesity?

Not for the prediabetes alone. However, if your doctor prescribes it for weight loss and documents obesity as a diagnosis, there is a small chance Medicare will cover it under that indication. This is less common than coverage for type 2 diabetes but worth asking your doctor about.

What if I switch from prediabetes to type 2 diabetes — does my coverage change?

Yes. Once you have a type 2 diabetes diagnosis in your medical record, Medicare Part D will cover Mounjaro automatically (assuming your plan includes it on the formulary, which most do). You do not need to reapply or request authorization.

Can I appeal if Medicare denies the prior authorization?

Yes. Your doctor can file a formal appeal, usually within 60 days of the denial. The appeal goes to an independent reviewer at the plan. Success rates are low for off-label prediabetes use, but it is an option if your doctor believes strongly that Mounjaro is medically necessary for you.

Is the Eli Lilly savings card the same as Medicare coverage?

No. The savings card is a manufacturer discount that works with commercial insurance or if you pay out of pocket. It typically does not work with Medicare because Medicare has its own payment rules. However, some people on Medicare have reported success using the card at the pharmacy — ask yours to try it.

What is the difference between a prior authorization and an appeal?

A prior authorization is the first request your doctor makes to Medicare asking for coverage. An appeal is what you file if that request is denied. The appeal goes to a different reviewer and includes additional medical evidence or arguments for why the drug should be covered.